Abdechakour ELKIHEL

Dr. Abdechakour ELKIHEL

orcid
PhD

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in Science Advances
Verified
Journal Article
Open access
NZNian Zhang
Nian Zhang
DDDinesh Dhumal
Dinesh Dhumal
SKShanny Hsuan Kuo
Shanny Hsuan Kuo
SLShi Qian Lew
Shi Qian Lew
PPPankaj D. Patil
Pankaj D. Patil
LPLing Peng
Ling Peng
The rapid emergence and spread of multidrug-resistant bacterial pathogens require the development of antibacterial agents that are robustly effective while inducing no toxicity or resistance development. In this context, we designed and synthesized amphiphilic dendrimers as antibacterial candidates. We report the promising potent antibacterial activity shown by the amphiphilic dendrimer AD1b , composed of a long hydrophobic alkyl chain and a tertiary amine-terminated poly(amidoamine) dendron, against a panel of Gram-negative bacteria, including multidrug-resistant Escherichia coli and Acinetobacter baumannii. AD1b exhibited effective activity against drug-resistant bacterial infections in vivo. Mechanistic studies revealed that AD1b targeted the membrane phospholipids phosphatidylglycerol (PG) and cardiolipin (CL), leading to the disruption of the bacterial membrane and proton motive force, metabolic disturbance, leakage of cellular components, and, ultimately, cell death. Together, AD1b that specifically interacts with PG/CL in bacterial membranes supports the use of small amphiphilic dendrimers as a promising strategy to target drug-resistant bacterial pathogens and addresses the global antibiotic crisis.

2 September 2021 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
AEAbdechakour ELKIHEL
Abdechakour ELKIHEL
CCCamille Christie
Camille Christie
CVCharlotte Vernisse
Charlotte Vernisse
TOTan-Sothéa Ouk
Tan-Sothéa Ouk
RLRomain Lucas-Roper
Romain Lucas-Roper
VSVincent Sol
Vincent Sol

27 June 2025 in Science Advances
Verified
Journal Article
Open access
XLXi Liu
Xi Liu
DDDinesh Dhumal
Dinesh Dhumal
PCPatricia Santofimia Castaño
Patricia Santofimia Castaño
JLJuan Liu
Juan Liu
MCMarion Casanova
Marion Casanova
LPLing Peng
Ling Peng
Cardiotoxicity, especially human ether-a-go-go–related gene (hERG)–related toxicity, is a leading cause of drug failure or market withdrawal. Reducing hERG binding to obviate potential cardiac toxicity is crucial. Nanotechnology has been applied to drug delivery for reducing drug toxicity and improving efficacy, but few studies have addressed hERG-related cardiotoxicity. We report the use of self-assembling dendrimer nanosystems for drug formulation and delivery, which effectively reduced hERG binding and associated toxicity while promoting therapeutic efficacy. Specifically, these dendrimer nanosystems efficiently encapsulated the antimalarial drug chloroquine, the anticancer agent doxorubicin, and the NUPR1 inhibitor ZZW115, all three having high affinity to hERG channels. These nanoformulations showed three- to eightfold reduced hERG binding affinity, which, in animal models, translated to abolished toxicity. These nanodrugs exhibited prolonged circulation, leading to enhanced accumulation at disease sites and improved treatment outcomes. This study highlights the potential of nanotechnology to reduce hERG binding and related toxicity while improving drug efficacy, offering valuable perspectives for drug development.

9 June 2022 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
AEAbdechakour ELKIHEL
Abdechakour ELKIHEL
CVCharlotte Vernisse
Charlotte Vernisse
TOTan‐Sothéa Ouk
Tan‐Sothéa Ouk
RLRomain Lucas
Romain Lucas
VCVincent Chaleix
Vincent Chaleix
VSVincent Sol
Vincent Sol

2 February 2023 in Gels
Verified
Journal Article
Open access
PDF file
AEAbdechakour ELKIHEL
Abdechakour ELKIHEL
CVCharlotte Vernisse
Charlotte Vernisse
TOTan-Sothea Ouk
Tan-Sothea Ouk
RLRomain Lucas-Roper
Romain Lucas-Roper
CVChaleix Vincent
Chaleix Vincent
VSVincent Sol
Vincent Sol
In the present work, we report on the synthesis of light-triggered antibacterial hydrogels, based on xylan chains covalently bound to meso-tetra(4-carboxyphenyl)porphyrin (TCPP). Not only does TCPP act as a photosensitizer efficient against Gram-positive bacteria, but it also serves as a cross-linking gelator, enabling the simple and easy building of xylan conjugate hydrogels. The hydrogels were characterized by infrared spectroscopy (ATR-FTIR), scanning electron microscopy (SEM), along with swelling and rheological tests. The antimicrobial activity of the hydrogels was tested under visible light irradiation against two Gram-positive bacterial strains, Staphylococcus aureus and Bacillus cereus. The preliminary results showed an interesting activity on these bacteria, indicating that these hydrogels could be of great potential in the treatment of skin bacterial infections with this species by photodynamic antimicrobial chemotherapy (PACT).

26 June 2026 in Comptes Rendus. Chimie
Verified
Journal Article
Closed access
AEAbdechakour ELKIHEL
Abdechakour ELKIHEL
JWJing Wu
Jing Wu
LPLing Peng
Ling Peng
Supramolecular dendrimers formed through the self-assembly of amphiphilic dendritic building blocks have emerged as powerful nanoplatforms that combine dendritic architectural features with dynamic adaptability. In contrast to conventional covalent dendrimers, self-assembling supramolecular dendrimers are readily accessible, structurally tunable, and capable of forming functional nanomicelles with large internal voids and multifunctional surfaces, enabling efficient drug and nucleic acid delivery as well as advanced biomedical imaging. This short Account summarizes our decade-long dedication to engineering self-assembling supramolecular dendrimers for biomedical applications, with a particular emphasis on molecular engineering that governs self-assembly, pharmaceutical agent loading and release, biodistribution, and biomedical performance. Collectively, our studies establish self-assembling supramolecular dendrimers as versatile and programmable platforms for next-generation nanomedicine.